Google
Trusted Resources: News & Events
Latest announcements and gatherings
2019 Cure Sickle Cell Initiative Annual Forum: Accelerating Scientific Priorities
Tuesday, November 19 – Thursday, November 21, 2019
Hilton Washington DC/Rockville Hotel & Executive Meeting Center
1750 Rockville Pike
Rockville, MD 20852
As part of the National Institutes of Health (NIH) Cure Sickle Cell Initiative, Gary H. Gibbons, MD, Director, National Heart, Lung, and Blood Institute (NHLBI), W. Keith Hoots, MD, Director, Division of Blood Diseases and Resources, NHLBI, and Edward J. Benz, Jr., MD, Executive Director of the NHLBI Cure Sickle Cell Initiative are convening this meeting to advance scientific discoveries in the field of curative therapies for sickle cell disease.
This 2.5 day meeting will engage attendees in innovative solution-discovery sessions to define the priorities and opportunities to pursue to accelerate and enhance our roadmap towards a cure. As a distinguished contributor in this field, your participation in this process will be essential to the success of the Initiative.
This event has ended.
+myBinderRelated Content
-
Care Team MembersYour Sickle Cell Care Team Managing you...
-
Our Family’s Journey With Sickle Cell DiseaseJune 19th is World Sickle Cell Day. We s...
-
Andre Marcel HarrisAndré Marcel Harris is committed to wor...
-
Representative Johnson Files Four Sickle Cell Disease Related BillsState Representative Jarvis Johnson (HD ...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
-
Sickle cell disease: Information for physicians and other health care professionalsSickle cell disease is a term for hemogl...
-
Robert H. Broyles, PhDRobert H. Broyles was founder and presid...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.